
Robert Gizicki MDCM, FRCSC, DABO
Dr Gizicki received his medical degree from McGill University and completed his residency in ophthalmology at the Université de Montréal, Québec. He then went on to complete a 2-year sub-specialty training in vitreo-retinal diseases and surgery at St Michael’s Hospital, University of Toronto, Canada. He then joined the retina group at Retina Surgical Associates and the Department of Ophthalmology at the University of British Columbia.
His interests are diverse and include retinal detachment repair, diabetic retinopathy treatment, complications of cataract surgery, and surgical performance analysis and benchmarking. He leads the clinical research program at Retina Surgical Associates, where he is the site principal investigator for multiple phase 3 and 4 clinical trials.
He is board-certified with the Royal College of Surgeons and Physicians of Canada as well as with the American Board of Ophthalmology. He is a member of many professional societies including the Canadian Ophthalmological Society, Canadian Retina Society, and the American Society of Retina Specialists.
Financial disclosure: Dr Gizicki has/had an affiliation (financial or otherwise) with a commercial organization:
- Roche
- Bayer
- Astellas
- Alcon
- Regenxbio
Sessions in which Robert Gizicki MDCM, FRCSC, DABO participates
Saturday 26 June, 2021
Learning ObjectivesAt the end of this session, participants will be able to:Describe new therapeutic options for the treatment of neovascular macular degenerationIntegrate key aspects of the evaluation of posterior uveitisOptimize management of submacular hemorrhageCanMEDS Roles: Medical Expert, Scholar
Sunday 27 June, 2021
Learning ObjectivesAt the end of this session, participants will be able to: List key issues in managing patients with glaucoma and corneal transplantsDescribe the “Value Proposition” of glaucoma management from the Patient’s PerspectiveReview vision screening options for stroke admissions through the pathway from emergency department to dischargeDescribe the ocular manifestation of Zika and Ebola infe...
Learning ObjectivesAt the end of this session, participants are able to:Describe new advances in macular degeneration with geographic atrophy, neovascular macular degeneration and diabetic retinopathyIntegrate multi-modal imaging in the management of retinal detachment repairAssess the impact of COVID-19 on retinal practicesCanMEDS Roles: Medical Expert, Scholar